The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: WPP Shares Surge As It Beats Forecasts

Fri, 09th Aug 2019 10:52

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------WPP, up 6.4%. The advertising company reported its second-quarter results slightly ahead of its internal expectations, with revenue rising by 2.3% to GBP4.03 billion. The company noted that an improvement in North America and the UK was partly offset by slower growth in Asia Pacific, Latin America, Africa & the Middle East and Central & Eastern Europe. WPP said its revenue in the six months to June 30 increased by 1.6% to GBP7.61 billion from GBP7.49 billion, but pretax profit fell by 44% to GBP478.2 million from GBP846.5 million. Profit nosedived because of an exceptional loss of GBP3.0 million, largely due to restructuring costs, compared to a gain of GBP114.0 million it generated last year in relation to the sale of its investment in Globant. Looking ahead, the company reiterated its full-year guidance for revenue less pass-through costs, which is expected to fall by no more than 2%. Revenue less pass-through costs in the half-year was GBP6.15 billion, same as last year, but down 2% on a like-for-like basis. ----------Astrazeneca, up 1.4%. The pharmaceutical company said drug Tagrisso significantly improved overall survival during its phase 3 Flaura trial in non-small cell lung cancer patients. The trial involved patients with locally-advanced or metastatic lung cancer and epidermal growth factor receptor mutations. It found a "statistically-significant and clinically-meaningful improvement" in overall survival compared to previous standard-of-care treatments. Overall survival was the secondary endpoint of the study. Flaura met its primary endpoint back in July 2017 when is demonstrated an improvement in progression-free survival - time lived with no disease progression or death. Astra said Tagrisso's safety and tolerability during the study was "consistent with its established profile".----------FTSE 100 - LOSERS----------International Consolidated Airlines Group, down 1.5%. It has been a dismal week for IAG's British Airways, after a jet was forced to land as smoke poured into the cabin, an IT glitch caused the cancellation of more than 100 flights, and the BA pilots union threatened to strike over pay.----------FTSE 250 - WINNERS----------Hikma Pharmaceuticals, up 7.5%. The pharmaceutical company's profit soared in the first half of 2019, led by a strong performance from its Generics business, prompting Hikma to raise its annual expectations. Hikma posted a 60% jump in pretax profit for the six months ended June 30 to USD226 million as revenue climbed 7.3% to USD1.05 billion. Generics led the charge, with revenue up 11% to USD368 million, benefiting from in-market product demand and recent launches. Injectables also performed well, with revenue up 5.4% to USD432 million. As a result, Hikma raised its annual guidance. The second best performer was G4S, up 6.3%, as the company said it will separate its cash management division in the first half of 2020 as part of a previously announced business review. The company, which also provides security services, reported a 3.8% rise in revenue for the six months to June-end, but profit fell on disposals, onerous contracts, exchange rate movements, restructuring and separation costs, and impairment charges.----------William Hill, up 6.2%. The bookmaker posted a narrowed loss for the 26 weeks to July 2 of GBP63.5 million compared to GBP819.6 million a year earlier, as revenue rose 1.1% to GBP811.7 million from GBP802.9 million. A year ago, William Hill recorded an impairment charge of GBP882.8 million in the Retail segment following the announcement of the UK government's decision to reduce the maximum stake on fixed-odds betting terminals. William Hill said that in the first half there was a decline in Retail revenue of 12% after the implementation of GBP2 maximum stake on the gaming machines from April. In Online, William Hill reported growth of 14% during the period, primarily resulting from the acquisition of Mr Green in Sweden. There was also growth of 40% in William Hill US, driven by expansion in the country after the US Federal ban on sports betting was overturned by Supreme Court in May 2018.----------G4S, up 3.9%. The company, which provides security services, said it will separate its cash management division in the first half of 2020 as part of a previously announced business review. It also reported a 3.8% rise in revenue for the six months to June-end, but profit fell on disposals, onerous contracts, exchange rate movements, restructuring and separation costs, and impairment charges. G4S said it has received a number of unsolicited interest from third parties to acquire parts or all of the Cash Solutions businesses. For the first half, G4S recorded pretax profit of GBP108 million, down 21% on GBP137 million recorded in the year ago period. Revenue increased to GBP3.81 billion from GBP3.67 billion.----------IWG, up 1.6%. The Regus office owner said it has entered into a second strategic partnership with TKP. IWG will divest its Taiwanese operations to TKP, and the parties have agreed an exclusive master franchise agreement for the country. The service office provider said the deal follows the agreement between IWG and TKP in April for the divestment of IWG's Japanese operations to TKP and related franchise agreement in respect of the Japan market. IWG will receive gross consideration of GBP22.7 million payable in cash at completion, which is expected to occur in September. Proceeds from the divestment will be used for IWG's general corporate purposes, it said.----------OTHER MAIN MARKET AND AIM - WINNERS----------Rambler Metals, up 24%. The gold and copper producer said output rose sharply in the second quarter of 2019 due to its mining process improvement programme. Rambler said its executive management changes and the improvement programme, which began midway through 2018, were responsible for a "consistently higher" ore production rate and a higher rate of copper contained in ore in the second 2019 quarter. Ore production in the second quarter ended June 30 was 1,239 dry tonnes per day, up from 1,036 dry tonnes per day the year before - a 20% improvement. Moreover, copper contained in ore produced in the second quarter was 17.2 dry tonnes per day versus 11.7 dry tonnes per day, up 47% year-on-year.----------Amerisur Resources, up 8.6%. The oil & gas producer said multiple companies have expressed an interest in acquiring the firm during its formal sale process. Amerisur said it is engaging with potential takeover parties "in a constructive and positive manner to achieve an outcome that maximises value for all our shareholders". Shareholders were advised to take no action until the formal sales process was completed, however. Amerisur put itself up for sale in July after it reported that there was interest in the company and its assets from other companies in the industry. Since then, the company rejected a USD260 million takeover proposal from Paris-listed firm Etablissements Maurel & Prom. Maurel & Prom has a number of assets in Colombia, where Amerisur also operates. ----------Xtract Resources, up 5.7%. The metals and minerals producer said historic data overview confirmed targets for fast-track drilling at the Eureka project in the central part of the Republic of Zambia. Xtract said drilling review indicates mineralisation in Eureka pit area remains open, with particular focus to the southeast. "We are pleased by the outcome of the interim review of the extensive exploration dataset that we have acquired for Eureka. The more we examine the historic information the more we are convinced that the strong structural and geochemical trends, along with significant drill intercepts and past mining history, can be indicators of substantial copper-gold orebodies on the property," said Executive Chair Colin Bird. ----------OTHER MAIN MARKET AND AIM - LOSERS----------Pennant International, down 24%. The training solutions provider said it now expects its annual results to come in "materially" below market expectations, due to the timeline for the award of certain potential contracts moving into 2020. Pennant expects to report earnings before interest, taxes, and amortization for 2019 of GBP1.8 million. In 2018, the company reported oprtaing profit of GBP3.2 million. Pennant said its costs reduction exercise in response to the delay to the award of the major programme is ongoing, although the benefits of this exercise will have limited impact on the second half. More positively, for the first half, Pennant expects to report revenue and Ebita loss ahead of management expectations, at GBP7.3 million and GBP1.5 million, respectively. ----------On the Beach, down 18%. The package holiday company issued a profit warning due to the weakness of sterling against the euro ahead of Brexit. On the Beach said it now expects its annual performance to fall below expectations as "the increased likelihood of a no deal Brexit" has caused sterling to devalue against the euro since the start of May, accelerating in late July and "continuing into August". Despite higher second-half demand, sterling weakness has caused "a significant increase" in On the Beach prices compared to "competitors with currency hedges". On The Beach didn't provide any information in its statement Friday on the currency hedging that it does, if any. Because On the Beach's main focus is on growing the business, relative price increases have made it tough to gain market share and maintain margins at the same time. It is for this reason that 2019 performance is expected to fall below the expectations of the On the Beach board.----------

More News
24 May 2022 07:09

Hikma's Siggi Olafsson stands down as CEO

(Sharecast News) - Drugmaker Hikma Pharmaceuticals revealed on Tuesday that chief executive Siggi Olafsson has resigned from both the role and the company's board of directors in order to pursue other opportunities.

Read more
13 May 2022 16:01

UK shareholder meetings calendar - next 7 days

Monday 16 May 
88 Energy LtdAGM
Allianz Technology Trust PLCAGM
Blackbird PLCAGM
BSF Enterprise PLCGM
Crossword Cybersecurity PLCAGM
DigitalBox PLCAGM
Ethernity Networks LtdAGM
Jubilee Metals Group PLCGM - re right of directors to allot equity securities for cash
Mast Energy Developments PLCAGM
Metal Tiger PLCAGM
Tuesday 17 May 
Accesso Technology Group PLCAGM
Capital & Regional PLCAGM
Chaarat Gold Holdings LtdAGM
Chesnara PLCAGM
Equals Group PLCAGM
European Assets Trust PLCAGM
Fidelity Japan Trust PLCAGM
Fintel PLCAGM
Fresnillo PLCAGM
GCP Asset Backed Income Fund LtdAGM
GENinCode PLCFull Year Results
Greggs PLCAGM
IQGeo Group PLCAGM
Kefi Gold & Copper PLCGM re share placing
Mears Group PLCAGM
Mercantile Investment Trust PLCAGM
Vitec Group PLCAGM
Vivo Energy PLCAGM
Wednesday 18 May  
ABCAM PLCAGM
abrdn PLCAGM in Edinburgh
Alliance Pharma PLCAGM
Burford Capital LtdAGM
Coats Group PLCAGM
CVC Credit Partners European Opportunities LtdAGM
EKF Diagnostics Holdings PLCAGM
Highcroft Investments PLCAGM
Impax Environmental Markets PLCAGM
JPMorgan American Investment Trust PLCAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Merchants Trust PLCAGM
PensionBee Group PLCAGM
Permanent TSB Group Holdings PLCAGM
PYX Resources LtdAGM
Riverstone Credit Opportunities Income PLCAGM
Schroder UK Public Private Trust PLCAGM
Science Group PLCAGM
Seplat Energy PLCAGM
TI Fluid Systems PLCAGM
Vesuvius PLCAGM
Thursday 19 May  
Bigblu Broadband PLCAGM
Brand Architekts Group PLCGM re takeover of InnovaDerma
Capital & Regional PLCAGM
Computacenter PLCAGM
Cornish Metals IncGM re equity raise
Dialight PLCAGM
Ebiquity PLCAGM
Eqtec PLCAGM
Essentra PLCAGM
Fevertree Drinks PLCAGM
Gamma Communications PLCAGM
Genuit Group PLCAGM
Headlam Group PLCAGM
Inchcape PLCAGM
InnovaDerma PLCGM re takeover by Brand Architekts
Irish Residential Properties REIT PLCAGM
K3 Business Technology Group PLCAGM
Light Science Tech Holdings PLCAGM
Live Co Group PLCGM
McColl's Retail Group PLCAGM
musicMagpie PLCAGM
Network International Holdings PLCAGM
Next PLCAGM
Pharos Energy PLCAGM
Property Franchise Group PLCAGM
Rotala PLCAGM
Smart Metering Systems PLCAGM
St James's Place PLCAGM
Tyman PLCAGM
Friday 20 May  
Bank of Cyprus Holdings PLCAGM
Croda International PLCAGM
Deliveroo PLCAGM
Georgia Capital PLCAGM
Hikma Pharmaceuticals PLCEGM re capital reduction
Keywords Studios PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 09:47

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 10:51

Signs of slowdown on the continent

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SIGNS OF SLOWDOWN ON THE CONTINENT (1051 GMT)

Read more
5 May 2022 09:24

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy.

Read more
5 May 2022 08:58

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100.

Read more
5 May 2022 08:02

Hikma cuts 2022 generics guidance due to drug launch delay

(Sharecast News) - Hikma Pharmaceuticals cut guidance for its generics business on Thursday, citing a delay to a drug launch.

Read more
29 Apr 2022 17:44

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.

Read more
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.